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Abstract: An electrospun mat of Eudragit E100 (EE100) (a cationic copolymer based on
dimethylaminoethyl methacrylate, butyl methacrylate, and methyl methacrylate) was used as a
delivery system for oregano ethanolic extract (OEE). Oregano is a biologically active material which
is widely used because of the antibacterial and antifungal activity. The oregano herb consists of
phenolic compounds, the main of which are rosmarinic acid and from essential oil—carvacrol. Such a
material could be an ideal candidate for oral drug systems. The influence of the EE100 concentration
in the OEE on the structure of electrospun mats, encapsulation efficiency, dissolution profile, release
kinetics and the stability of biologically active compounds was investigated. The concentration of the
solution is a critical parameter for the structure and properties of electrospun mats. The diameter
of electrospun fibers increased with the increase of EE100 concentration in the OEE. Electrospun
mats obtained from 24% to 32% EE100 solutions showed high encapsulation efficiency, quick release
and high stability of rosmarinic acid and carvacrol. Dissolution tests showed that 99% of carvacrol
and 80% of rosmarinic acid were released after 10 min from electrospun nano-microfiber mats
and capsules obtained from such formulations. The stability tests showed that physicochemical
properties, dissolution profiles, and rosmarinic acid and carvacrol contents of the formulations were
not significantly affected by storage.
Keywords: electrospun; rosmarinic acid; carvacrol
1. Introduction
Many recent investigations have revealed benefits of natural products for human health.
Natural compounds from plants demonstrate various biological effects, including antibacterial,
antimalarial, antifungal and antioxidant activity [1]. Their biological activity is attributed to the
presence of phenolic compounds and essential oils, which are the main constituents of multiple
pharmacologically active products [2]. Turkish oregano (Origanum onites L.) (hereinafter referred to
as oregano) is rich in phenolic compounds, the main of them being rosmarinic acid, with powerful
antibacterial and antifungal properties [3,4]. Furthermore, oregano essential (OE) oils have been shown
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to possess antioxidant, antibacterial, antifungal, diaphoretic, carminative, antispasmodic, and analgesic
activities [5]. In recent years, the efficiency of essential oils from oregano species has been reported
in many studies. Basser et al. identified carvacrol as the main phenolic compound responsible for
biological activities of oregano [6]. However, various natural products have limited bioavailability due
to the low solubility, which affects their absorption by human body. Furthermore, stability issues of
natural products like hydrolysis, oxidation, and photolysis urge the need for stabilization. The limited
solubility and stability problems can be controlled by polymer nanoparticles using different carrier
categories [7,8].
With the increasing popularity of nanotechnology, electrospun nano-microfibrous materials
have drawn attention to their potential applications in different biomedical areas, such as drug
delivery, wound dressing, scaffolds, minitablets, tablets, and cosmetic masks [9–11]. Electrospun
nano-microfibers are used as drug carriers in the drug delivery systems due to their highly functional
characteristics and different controlled drug release profiles such as immediate, sustained, and biphasic
release. The preparation of electrospun nano-microfiber materials has attracted particular interest
because of its simplicity and low costs, the porosity and high surface area-to-volume ratios of the
fibers, and the wide variety of materials, which can be processed [12,13]. Moreover, the fibers have
high encapsulation efficiency, as there is no loss of active substance during the preparation [14–17].
Synthetic polymers such as polycaprolactone, polyvinylpyrrolidone and Eudragit S100, commonly
used in electrospinning, provide great flexibility in synthesis, processing and modification of
nano-microfibers materials and possess good mechanical properties and stability in the body [18].
For the preparation of electrospun nano-microfiber mats as a polymer carrier, Eudragit E100
(EE100) has been selected. EE100 is a pH-dependent polymer, soluble in gastric fluid and swelling
at pH lower than 5.0. It has low viscosity and high pigment biding and can be applied in different
pharmaceutical dosage forms. EE100 can be used as a film/insulation coating material, which is
suitable for taste/odor masking and light/moisture protection [19]. Moreover, it can be used in
nanoparticles production by blending polylactic glycolic acid and EE100 for plasmid delivery [20], [21].
Various polymeric nano-microfibers have been already produced by electrospinning techniques.
Therefore, active agent encapsulating polymeric films and electrospun nano-microfibers have been
studied previously. Munhuweyi with co-authors [22] have investigated physical and antimicrobial
activities of encapsulated cinnamon and OE oils using β-cyclodextrin (β-CD) and electrospun
chitosan/polyvinylalcohol/β-CD/OE nanofibrous films [22].
Moreover, the electrospinning technique has been described in several articles as the potential
method of formation of drug-loaded electrospun nano-microfibers, used as a new solid matrix for
solid dosage forms. Several advantages have been identified of electrospun nano-microfibers used for
drug delivery systems: high porosity of these structures can facilitate fast wetting, which promotes a
rapid release of the drug. Moreover, drugs can be incorporated into electrospun nano-microfibers in
an amorphous form, which can be utilized to increase both the apparent solubility and the dissolution
rate of the drug [13,23]. Hamori with co-authors [24] have prepared nano-microfiber-based capsules
for oral use including uranine and nifedipine drugs for a controlled release delivery system using
methacrylic acid copolymer (MAC, Eudragit® S100). The in vitro release tests of uranine and nifedipine
from the nanofiber packed capsules and milled powder of nanofiber packed capsules showed efficient
results compared to capsules of a physical mixture of MAC and each drug. This study investigates the
potential of natural active compounds-loaded electrospun nano-microfiber mats as a new solid matrix
for capsules. The influence of EE100 concentration in oregano extract on the structure, encapsulation
efficiency, stability, dissolution profile and release of biologically active compounds from electrospun
mats was investigated.
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2. Results and Disscusion
2.1. Structure Analysis
It is well known [25] that the structure of electrospun mats depends upon polymer and solvent
nature, solution properties (viscosity, conductivity, and surface tension), processing parameters
(applied voltage, and distance between electrodes) and electrospinning environmental parameters.
In this study, the content of EE100 in the oregano ethanolic extract (OEE) was varied and sample
compositions are shown in Table 1. From the data presented in Table 1 and SEM images in Figure 1, it
can be seen that the structure of electrospun mats and the diameter of electrospun fibers depended
on the content of EE 100 in OEE in an electrospinning solution. In the case of E-8 sample, the EE100
polymer content was too small to obtain electrospun fibers of required quality. Therefore, in this case,
after the eletrospraying process, only polymer spots were formed on the support material (Figure 1A).
Increased electrospinning solution viscosity, and decreased conductivity with increase of the OEE
content influenced the increase of electrospun fibers diameter (Table 1 and Figure 1A–E). With the
content of 40 wt. % of EE100 in the electrospinning solution (E-40 sample), the average diameter of
electrospun fibers increased 6 times, compared to that of E-16 sample.
Table 1. Influence of amount of EE100 in the OEE on the solution viscosity, the conductivity and the
diameter of electrospun fibers.
Sample Code The Content of EE100
in the OEE, wt. %
Viscosity,
mPa·s (±∆)
Conductivity,
µS/cm (±∆)
Electrospun Mat
Average of Electrospun
Fibers Diameter, nm
Standard
Deviation, nm
E-8 8 2.2 ± 0.01 76.1 ± 0.87 – –
E-16 16 34.6 ± 0.02 54.3 ± 0.33 199.7 67.6
E-24 24 79.0 ± 0.01 39.9 ± 1.89 326.1 110.0
E-32 32 263.1 ± 0.07 36.5 ± 1.65 1210.4 507.9
E-40 40 552.0 ± 0.23 36.0 ± 1.45 3101.4 1120.0
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Figure 1. SEM images of electrospun EE100 in OEE mats at various EE100 contents (%): (A) E-8; (B) 
E-16; (C) E-24; (D) E-32; (E) E-40. Magnification: 1000×, scale bar: 50 µm, and magnification: 10,000×, 
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Analysis of SEM images showed that electrospun mats obtained from the solutions of OEE with 
16 wt. % and 24 wt. % of EE100 (E-16 and E-24) consisted of uniform, thin nano-microfibers (average 
diameters of 200 ± 67 nm and 326 ± 110 nm, respectively). The mats, formed from microfibers with 
average diameters of 1210 ± 508 nm and 3101 ± 1120 nm, respectively, were obtained from 
electrospinning solutions with higher EE100 content (Figure 1D,E). 
It was determined that 99% and 76% of the fibers had a diameter up to 400 nm when contents of 
EE100 in OEE electrospinning solutions were 16 wt. % and 24 wt. %, respectively (E-16, and E-24, 
Figure 2A). The thinnest fibers have been formed from the 16 wt. % EE100 solution (E-16). It was 
determined that 61% and 7% of nano-microfibers had a diameter up to 200 nm, when EE100 
solutions with respective contents of EE100 of 16 wt. % and 24 wt. % were used (E-16, and E-24, 
Figure 2B). 
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Figure 1. SEM images of elect ospun EE100 in OEE mats at various EE100 contents (%): (A) -8;
(B) E-16; (C) E-24; (D) E-32; (E) E-40. Magnification: 1000×, scale bar: 50 µm, and magnification:
10,000×, scale bar: 5 µm.
Analysis of SEM images showed that electrospun mats obtained from the soluti ns of OEE with
16 wt. % and 24 wt. % of EE100 (E-16 and E-24) consisted of uniform, thin ano-microfibers (average
diameters of 200 ± 67 nm and 326 ± 110 nm, respectively). The mats, formed from icrofibers
with average diameters of 1210 ± 508 nm and 3101 1120 nm, respectively, were obtained from
electrospinning solutions with higher EE100 content (Figure 1D, ).
It was determined that 99% an 76% of the fibers h d a diameter up to 400 nm when contents
of EE100 in OEE electrospinning solutions were 16 wt. % and 24 t. %, respectively (E-16, and E-24,
Figure 2A). The thinnest fibers have been formed from the 16 wt. % EE100 solution (E-16). It was
determined that 61% and 7% of nano-microfibers had a diameter up to 200 nm, when EE100 solutions
with respective contents of EE100 of 16 wt. % and 24 wt. % were used (E- , and E-24, Figure 2B).
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2.2. Encapsulation Efficiency (EE) eter ination
EE is an i portant para eter of for ulation. The a ount of active co pounds (load) in a given
eight of nano-microfibers can be found from the formulation’s composition, when the extract is fully
encapsulated by the polymer. However, in practice, the materials used to prepare nano-microfibers
formulation would not be fully encapsulated. The actual amounts of rosmarinic acid and carvacrol in
prepared nano-microfiber mats were determined by high-perfor ance liquid chromatography. As
illustrated in Table 2, the E-32 formulation of electrospun mats (the diameter of fibers varied from 400
to 2400 nm (Figure 2A)) was the best in terms of EE of rosmarinic acid (85.6%) and carvacrol (91.8 ).
Furthermore, the electrospun ats of E-24 formulation also showed high EE values for rosmarinic
acid (70.45%) and carvacrol (87.7%) and the diameter of fibers was nano-microsized with the average
fiber diameter of 326 ± 110 nm, whereas the E-16 formulation electrospun mats (the dia eter of
fibers varied from 150 to 400 nm, the average fiber diameter: 200 ± 68 nm) had the lowest EE of
rosmarinic acid (50.23%) and carvacrol (61.91%). It could be related to the content of EE100 in the OEE
solutio being too low fully cover the active compounds and resulting in a decreased EE. The relatively
high EE of carvacrol is related to the hydrophobic nature of polymer and carvacrol. However, the
successful encapsulation of the ater-soluble agents (rosmarinic acid) in the hydrophobic polymers
(EE100) still prese ts challenges in high drug loading and their denaturation during t e formulation
process [26,27]. As compared to our previous studies, where oregano extract microcapsules were
prepared by a spray-drying technique and the wall materials were gumi arabic and maltodextrin,
the EE has increased 12.9 times for carvacrol and 2.4 times for rosmarinic acid (p < 0.05) using a
polymer electrospining method [28]. The result shows that p lymers make strong core–shell structure
to increase the EE.
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Table 2. Encapsulation efficiency (EE) of prepared nano-microfibers with oregano ethanolic extract.
Sample Code EE of Carvacrol (%) EE of Rosmarinic Acid (%)
E-8 - -
E-16 61.91 ± 2.34 50.23 ± 1.13
E-24 87.72 ± 1.23 a 70.45 ± 2.73 d
E-32 91.8 ± 3.4 a,b 85.6 ± 1.11 d,e
E-40 67.9 ± 1.49 a,b,c 60.2 ± 1.29 d,e,f
a p ≤ 0.05 vs. E-16; b p ≤ 0.05 vs. E24; c p ≤ 0.05 vs. E32; d p ≤ 0.05 vs. E-16; e p ≤ 0.05 vs. E-24; f p ≤ 0.05 vs. E-32.
2.3. In Vitro Drug Release
According to EE results, in vitro drug release tests were used for E-24 and E-32 formulations.
The quality of produced nano-microfibers mats and prepared capsules by using milling was defined
by the release profile of OEE active compounds rosmarinic acid and carvacrol. The dissolution
profiles of nano-microfibers mats and capsules of formulations E-24 and E-32 are shown in Figure 3.
The concentrations were determined by extrapolation of the calibration curve, and a graph of present
release over time was plotted.
Molecules 2019, 24, x FOR PEER REVIEW  6 of 13 
 
E-16 61.91 ± 2.34 50.23 ± 1.13 
E-24 87.72 ± 1.23 a 70.45 ± 2.73 d 
E-32 91.8 ± 3.4 a,b 85.6 ± 1.11 d,e 
E-40 67.9 ± 1.49 a,b c 60.2 ± 1.29 d,e,f 
a p ≤ 0.05 vs E-16; b p ≤ 0.05 vs E24; c p ≤ 0.05 vs E32; d p ≤ 0.05 vs E-16; e p ≤ 0.05 vs E-24; f p ≤ 0.05 vs E-32. 
2.3. In vitro Drug Release 
According to EE results, in vitro drug release tests were used for E-24 and E-32 formulations. 
The qu lity of produced nano-microfibers mats and prep ed apsules by using milling was efined 
by the release p file of OEE ctive compounds rosmarinic acid and carvacrol. The dissolution 
profiles of nano-microfibers mats and capsules of formulations E-24 and E-32 are shown in Figure 3. 
The concentrations were determined by extrapolation of the calibration curve, and a graph of 
present release over time was plotted. 
 
Figure 3. Release of rosmarinic acid and carvacrol from E-24 and E-32 nano-microfibers mats and 
E-24 and E-32 formulation capsules in vitro. 
The results showed that electrospun nano-microfiber mats had 2.5 times higher dissolution 
profile of carvacrol in the first 3 min compared to that of the capsules (Figure 3). Moreover, it was 
observed from the dissolution data that more than 75% of the carvacrol was released from the E-24 
and E-32 formulations nano-microfiber mats and capsules during the first 5 min. The in vitro data of 
carvacrol release from E-24 and E-32 formulations mats and capsules showed that about 100% of the 
active compounds were released after 10 min. It was revealed that there were no significant 
differences between E-24 and E-32 formulations fiber mats and capsules (Figure 3). High dissolution 
data influenced the choice of EE100 as a drug carrier, which plays an important role in drug delivery 
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The results showed that electrospun nano- icr fiber mats had 2.5 times igher diss lution
profile of carvacrol in the first 3 min compared to that of the capsules (Figure 3). Moreover, it was
observed from the dissolution data that more than 75% of the carvacrol was released from the E-24
and E-32 formulations nano-microfiber mats and capsules during the first 5 min. The in vitro data
of carvacrol release from E-24 and E-32 formulations mats and capsules showed that about 100%
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of the active compounds were released after 10 min. It was revealed that there were no significant
differences between E-24 and E-32 formulations fiber mats and capsules (Figure 3). High dissolution
data influenced the choice of EE100 as a drug carrier, which plays an important role in drug delivery
systems. EE100 has low viscosity, high pigment binding capacity, good adhesion and low polymer
weight gain, which enhance the bioavailability of active compounds (carvacrol is a monoterpenoid
phenol), in particular those with low aqueous solubility [29]. Moreover, the fast dissolution rate of
electrospun nano-microfiber mats has been attributed to a number of properties, which include the
hydrophobic nature of polymer and carvacrol, the high surface area of the nano-microfiber matrix
structure and the molecular dispersion of the carvacrol [30].
In Figure 3, the results of dissolution tests performed to compare release of rosmarinic acid from
the E-24 and E-32 formulations nano-microfiber mats and capsules are presented. The same tendency
was observed with rosmarinic acid: electrospun nano-microfibers mats had significantly 5.0 times
higher dissolution profile of rosmarinic acid after first 3 min as compared to formulations capsules
(Figure 3). The slower rosmarinic acid release from the capsules is presumably due to the lower specific
surface area exposed to the media compared to the electrospun mat. In capsules, the formulation
may affect the network porosity influencing the capacity of the dissolution media to diffuse into the
capsule matrix [30]. The in vitro data of rosmarinic acid release from electrospun nano-microfibers
mats and capsules showed that about 78% of the active compounds were released after 10 min. Lower
release results are affected by structure interactions between polymer and rosmarinic acid. Rosmarinic
acid is the ester of caffeic acid and 3,4-dihydroxyphenyl lactic acid. EE100 contains strong acceptor
groups (tertiary amines), but has less hydrogen-bonding potential. EE100 forms hydrogen bonds with
rosmarinic acid through phenolic OH interactions with its dimethylamin groups, but because of the
low number of OH groups in the polyphenol structure, it is complicated to form strong bonds [31].
Consequently, it was revealed that there was no significant difference between mat and capsule
fillings after milling. The similar results were obtained in References [30,31].
2.4. Release Kinetics
The release versus time profiles from E-24 and E-32 samples electrospun nano-microfibers
mats and capsules were shape-fitted against zero-order, first-order and Korsmeyer–Peppas kinetic
models. The correlation was best reflected by Korsmeyer–Peppas and first-order models (Table 3).
The established zero-order and first-order mathematical models, accordingly, were fitted to the drug
release versus time profiles, in hope to better elucidate the kinetics of rosmarinic acid and carcvacrol
release (Table 3). First-order results signified the independence of rate versus the concentrations
of active compounds along each side of the membrane. In practice, such findings more often
reflect a pseudo first-order model, in which dissolution rates are concentration-dependent. Regular
time-release kinetics, for instance, would impart substantial advantages to drug delivery in medicine,
and agriculture. Hence, the findings in Table 3 also imply that E-24 and E-32 could serve as reservoir
systems for the continuous delivery of encapsulated carvacrol and rosmarinic acid.
Table 3. Kinetic release profile model analysis of carvacrol from E-24 and E-32 formulations.
Kinetic Model E-24 Nano-Microfiber
Mats
E-24 Nano-Microfiber
Capsules
E-32 Nano-Microfiber
Mats
E-32 Nano-Microfiber
Capsules
Zero-order
R2 0.830 0.896 0.787 0.847
Equation y = 6.8494x + 12.453 y = 6.8333x + 6.8333 y = 7.0651x + 15.618 y = 7.0076x + 9.2411
First-order
R2 0.969 0.989 0.994 0.985
Equation y = −0.0951x + 2.0322 y = −0.0821x + 2.0586 y = −0.138x + 2.1015 y = −0.0923x + 2.0492
Korsmeyer–Peppas
R2 0.990 0.986 0.983 0.979
Equation y = 85.367x + 1.3845 y = 81.831x − 2.2099 y = 90.069x + 2.9938 y = 85.997x − 1.2791
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The release mechanisms of carvacrol and rosmarinic acid from electrospun mats and capsules
were analyzed using the Korsmeyer–Peppas model [31]. This model concerns the release of drugs from
cylindrical structures and predicts whether the release of the compound from a matrix follows Fickian
diffusion, through determination of the coefficient “n” estimated from the linear regression of the log
(cumulative release) as a function of log (time). The “n” determined from both release curves was
above 0.45, with a correlation value (R2) of 0.98 and 0.97 for carvacrol and rosmarinic acid, respectively.
The release mechanism of both bioactives was mainly due to the swelling of the nano-microfibers that
influenced their release. Wongsasulak and co-authors [31,32] also reported that the swelling of the
matrix (electrospun polymers of zein, poly(ethylene oxide), and chitosan) triggered the release of the
bioactive (α-tocopherol) according to the Korsmeyer–Peppas model.
2.5. Stability Studies
The stability studies of electrospun nano-microfiber mats (E-24 and E-32 samples) and capsules
included the organoleptic evaluation, average weight of capsule contents, rosmarinic acid and carvacrol
stability in formulations and their dissolution tests under long-term conditions for 6 months and
accelerated stress conditions for 6 months. Table 4 demonstrates the stability test results of different
formulations. The formulations did not show any physical changes during the study period.
Furthermore, the content of rosmarinic acid and carvacrol in the E-24 and E-32 formulations
nano-microfibers mat and capsules after storage had no significant differences as compared with the fresh
ones. The contents of rosmarinic acid and carvacrol in all formulations were more than 99 ± 0.5%.
The results revealed that there were no significant changes (p > 0.05) of dissolution rate of rosmarinic
acid after aging capsules and microfiber mats under accelerated stress conditions (temperature: 40 ± 2 ◦C,
relative humidity: 75 ± 5%) and long-term conditions (temperature: 25 ± 2 ◦C, relative humidity:
60 ± 5%).
The results mentioned above could be explained by interactions between active compounds and
EE100 molecular structures. As it was mentioned above, EE100 ionic interactions play a significant
role in both drug–polymer miscibility and active compounds physical stability, because of flavonoid
polymer hydrogen bonding forces in the system [3,17,33].
Table 4. Electrospun nano-microfibers mats and capsules properties during 6 months storage under
accelerated and long-term conditions (n = 3).
Samples
Results
Carvacrol Content (%) Rosmarinic Acid Content (%)
Initial 3 Months 6 Months Initial 3 Months 6 Months
A. Accelerated conditions (temperature: 40 ± 2 ◦C and relative humidity: 75 ± 5%).
E-24 nano-microfiber mats 31.05 ± 0.9 30.9 ± 0.3 29.8 ± 0.3 21.89 ± 0.3 19.51± 0.8 19.46 ± 0.45
E-32 nano-microfiber mats 30.5 ± 0.01 29.7 ± 0.09 28.9 ± 0.4 20.8 ± 0.7 19.97 ± 0.2 19.09 ± 0.7
E-24 nano-microfiber capsules 30.5 ± 0.01 29.7 ± 0.09 28.9 ± 0.4 20.8 ± 0.7 19.97 ± 0.2 19.09 ± 0.7
E-32 nano-microfiber capsules 30.6 ± 0.3 29.05 ± 0.32 28.09 ± 0.17 20.6 ± 1.2 19.9 ± 0.23 19.7 ± 0.89
B. Long-term conditions (temperature: 25 ± 2 ◦C and relative humidity: 60 ± 5%).
E-24 nano-microfiber mats 31.3 ± 0.2 31.04 ± 0.6 30.7 ± 0.5 19.7 ± 0.45 19.4 ± 0.78 19.0 ± 0.89
E-32 nano-microfiber mats 30.6 ± 0.3 29.6 ± 0.9 28.45 ± 0.19 20.9 ± 0.4 19.9 ± 0.11 19.45 ± 0.19
E-24 nano-microfiber capsules 29.8 ± 0.01 29.1 ± 0.76 29.0 ± 0.76 19.7 ± 0.23 19.5 ± 0.7 19.0 ± 0.54
E-32 nano-microfiber capsules 30.7 ± 0.9 29.05 ± 0.32 29.01 ± 0.31 20.2 ± 0.6 19.52 ± 0.75 19.32 ± 0.87
Results are presented mean ± SD (n = 6, p ≥ 0.05). No significant differences between compared
groups (E-24 nano-microfiber mats, E-32 nano-microfiber mats, E-24 nano-microfiber capsules, and
E-32 nano-microfiber capsules) in different time periods (initial, 3 months, and 6 months) of carvacrol
and rosmarinic acid content were observed.
3. Materials and Methods
Dried Origanum onites L. herb was obtained from “I˙nanTarım ECO DAB”, Antalya, Turkey.
The Herbarium of the Department of Drug Technology and Social Pharmacy, Lithuanian University
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of Health Sciences holds the voucher specimens (No. L170711). Ethanol (96%) for extraction was
purchased from Vilniaus degtine˙ (Vilnius, Lithuania). EE100 was supplied from Evonik (Essen,
North Rhine-Westphalia, Germany). The water used in HPLC and for sample preparation was
produced with a Super Purity Water System (Millipore, Bedford, MA, USA). HPLC eluents: methanol
(99.95%) was purchased from Carl Roth GmbH (Karlsruhe, Germany) and acetic acid (99.8%) from
Sigma-Aldrich (St. Louis, MO, USA). Standards for HPLC analysis: carvacrol (>98%) was purchased
from Sigma-Aldrich (St. Louis, MO, USA) and rosmarinic acid (>98%) was from ChromaDex
(Santa Ana, TX, USA).
3.1. Preparation of Oregano Ethanol Extract
Prior to the extract preparation, oregano herb was ground in a cross beater mill IKA A11 Basic
Grinder (IKA Works, Staufen, Germany) and sieved using a vibratory sieve shaker AS 200 basic (Retsch,
UK) equipped with a 125µm sieve. The powdered material (100 g) was extracted with 1000 mL of 90%
(v/v) ethanol in a round bottom flask by heat-reflux extraction performed in a water bath Memmert
WNB7 (Memmert GmbH & Co. KG, Schwabach, Germany) at 95 ◦C for 4 h. The prepared extract was
filtered using a vacuum filter. These conditions were determined as the best for the extraction of main
active compounds of Turkish oregano in our previous study [34].
3.2. Preparation of Electrospinning Solutions
Various amounts of the EE100 granules were soaked in the OEE and magnetically stirred for 24 h
at room temperature in order to obtain homogenously dissolved solutions. The polymer amounts in
solutions were 8 wt. %, 16 wt. %, 24 wt. %, 32 wt. % and 40 wt. %. The solutions were degassed
without stirring for 1 h prior to electrospinning.
3.3. Viscosity, and Conductivity of the Electrospinning Solution
The viscosity of EE100 solution in the OEE was measured by a rotational viscometer Alpha
series (Fungilab, Barcelona, Spain) equipped with L1 spindles at 25 ◦C and a 10 rpm shear rate.
The measurement was taken after 10 s. The conductivity of EE100 solution in the OEE was measured
by the HQ40d portable multi meter (Hach, Loveland, CO, USA) at room temperature (25 ± 1 ◦C).
3.4. Electrospinning Process
The materials from nano-microfibers were formed using “NanospiderTM“ (Elmarco, Liberec,
Czech Republic) electrospinning equipment. Electrospun mats from EE100/OEE solution formation
parameters were following: applied voltage U = 70 kV, distance between electrodes L = 13 cm,
temperature of environment T = 19 ± 2 ◦C and relative humidity ϕ = 40 ± 4%. Fiber-collecting time
on the support material was 6 min.
3.5. Characterization of Electrospun Mats
The morphology of electrospun mats was determined using a scanning electron microscope SEM
S-3400N (Hitachi, Tokyo, Japan). SEM images (magnification: 10,000×, scale bar: 5 µm; magnification:
1000×, scale bar: 50 µm; and magnification: 100×, scale bar: 500 µm) were analyzed. The diameter of
nano-microfibers was evaluated using SEM images and software NIS-Elements D (Nikon Corporation,
Tokyo, Japan). The average of nano-microfibers diameter was calculated from 100 measurements of
SEM images (magnification: 10,000×, scale bar: 5 µm).
3.6. Quantitative Analyses
High-performance liquid chromatography (HPLC) analysis was carried out using Waters 2695
chromatography system (Waters, Milford, MA, USA) equipped with Waters 996 PDA detector.
Data were collected and analyzed using a PC and the Empower 2 chromatographic manager system
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(Waters Corporation, Milford, USA). For determination of rosmarinic acid and carvacrol, an ACE 5
C18 250 × 4.6 mm column (Advanced Chromatography Technologies, Aberdeen, Scotland) was used.
3.6.1. Preparation of Electrospun Mats for HPLC Analysis
For determination of rosmarinic acid and carvacrol, 50 mg of the prepared electrospun mats were
accurately weighed and dispersed in 10 mL methanol in a volumetric flask and extracted for 10 min in
an ultrasound bath (Memmert WNB7 water bath, Memmert GmbH & Co. KG, Schwabach, Germany).
The prepared solution passed through a 0.45 µm diameter membrane filter for HPLC analysis.
3.6.2. HPLC Conditions for Determination of Rosmarinic Acid
The mobile phase was composed of solvent A (methanol) and solvent B (0.5% (v/v) acetic acid
in water). The following linear gradient elution profile was used: 95% A/5% B—0 min, 40% A/60%
B—40 min, 10% A/90% B—41–55 min, 95% A/5% B—56 min. The flow rate was 1 mL/min and the
injection volume was 10 µL. The effluent was determined at a wavelength of 329 nm. The quantification
was carried out by the external standard method. The linear calibration curve was made (R2 = 0.999),
and the peak areas were used for quantification [34].
3.6.3. HPLC Conditions for Determination of Carvacrol
For determination of carvacrol, an ACE 5 C18 250 × 4.6 mm column (Advanced Chromatography
Technologies, Aberdeen, Scotland) was used. The mobile phase was composed of methanol and water
(60/40, v/v). The flow rate was 0.6 mL/min and the injection volume was 10 µL. The absorption was
measured at 275 nm. The quantification was carried out by external standard method. The calibration
curve was made (R2 = 0.999) [34].
3.7. Encapsulation Efficiency of Rosmarinic Acid and Carvacrol
EE, also known as active retention, is defined as the ratio of the concentration of encapsulated
active ingredient (practical load) to its initial concentration (theoretical load) at the beginning of the
encapsulation process. It was calculated by the equations adopted from Panda et al. [35,36]:
EE (%) =
Practical load
Theoretical load
× 100 (1)
3.8. Preparation of Capsule Fillings from Prepared Nano-Microfiber Mats
For preparation of powder, nano-microfiber mats were crushed by a PM-100 planetary mill
(Retsch Co., Ltd., Germany) by adding 10 g of zirconium balls with a diameter of 1.0 mm by using a
rotation speed of 300 rpm, and the procedure was performed for 3 h. The milled powder was then
filled into number five gelatin capsules [32]. The capsules were filled using the manual capsule-filling
machine (Capsuline, Pompano Beach, FL, USA).
3.9. Determination of Dissolution Profiles and Their Variability
Dissolution profiles of the prepared capsules and mats were determined with SOTAX AT 7 smart
(Sotax, Allschwil, Switzerland) using the basket method at 50 rpm in 500 mL of artificial gastric juice
(AGJ) without pepsin with a pH value of 1.5 at 37 ± 0.5 ◦C. Five milliliters of samples were taken from
dissolution vessels manually at the time points of 1, 3, 5, 7, 10, 15, 20, 25, 30, 45 and 60 min, filtered
through a 0.45 µm disposable filters and analyzed by HPLC for determination of active compounds.
The dissolution media was then replaced by 5 mL of the fresh dissolution fluid to maintain a constant
volume. The mean value of nanoparticles of six samples and a standard deviation for each sample
were calculated. The evaluation of dissolution profiles was carried out in triplicate.
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3.10. Stability Studies
Four ounce amber glass containers, each containing 30 capsules and microfibers mats, were
kept according to The International Council for Harmonisation of Technical Requirements for
Pharmaceuticals for Human Use (ICH) guidelines for the long-term storage conditions in standard
atmosphere (temperature: 25 ± 2 ◦C, and relative humidity: 60 ± 5%). The required containers were
withdrawn after 0, 3, and 6 months in triplicate for analysis. The four ounce amber glass containers
were also subjected to accelerated storage conditions at 40 ± 2 ◦C and with a relative humidity of
75 ± 5%, and the samples were withdrawn after 0, 3 and 6 months of storage. The main active
ingredients (rosmarinic acid and carvacrol) in the capsules and nano-microfiber mats were rosmarinic
acid and carvacrol. Organoleptic evaluation, identification and quantified tests (by HPLC) were
performed and the average weight of contents was determined to evaluate the storage influence on the
stability of the capsules and mats.
3.11. Statistical Analysis
The results were analyzed by one-way analysis of variance (ANOVA) followed by a Tukey’s
multiple comparison test with the software package Prism v. 5.04 (GraphPad Software Inc., La Jolla,
CA, USA). The level of significance was taken as a value of p < 0.05.
4. Conclusions
In this study, the electrospun nano-microfiber mats with the OEE were investigated with respect
to their physical characteristics: structure, compounds interaction, encapsulation efficiency, dissolution
rate and release kinetic models. The content of EE100 in the electrospinning solution is a critical
parameter for the structure and properties of electrospun mats. The diameter of electrospun fibers
increases with the increase of EE100 polymer content in the solution. The results revealed optimal
traits in OEE formulations with 24% and 32% of EE100 (E-24 and E-32 formulations).
Furthermore, encapsulation efficiency improved with the increase of EE100 polymer concentration.
A higher polymer concentration resulted in electrospun mats with higher fibers diameter, smaller pores
and lower free motion of active compounds, which lead to the increase of effective efficiency values.
Moreover, the dissolution rate of the more promising formulations of E-24 and E-32 showed high
release of carvacrol and rosmarinic acid from both formulations. However, no significant differences
between formulations and between capsule fillings were found. During storage, the formulations E-24
and E-32 showed high stability.
According to the data obtained, the dissolution rate versus time profiles of E-24 and E-32 mats and
capsule fillings were shape-fitted against zero-order, first-order and Korsmeyer–Peppas kinetic models.
Without exception, the first-order and Korsmeyer–Peppas models reflected the best correlation.
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